Teva shares surge after announcing global opioid settlement
Teva CEO Schultz likely won't renew employment contract: reports
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva's flagship drug Austedo scores new approval at the FDA
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals (@TevaUSA) / Twitter
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva Pharmaceuticals (@TevaUSA) / Twitter
Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | The National Association of Free & Charitable Clinics
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceuticals - Wikipedia
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Articles with Teva Pharmaceuticals, Inc.
